USANA HEALTH SCIENCES, INC. Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities
USANA HEALTH SCIENCES, INC. (USNA) reported Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities of $0 for the 12-month period ending 2021-01-02, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities · last filed 2022-03-01
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2021-01-02 was $0.00.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2019-12-28 was $0.00.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2019-09-28 was $3.00M.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for the quarter ending 2019-06-29 was $23.86M.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2019.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2019 was $63.54M, a 177.98% increase from fiscal 2018.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2018 was $22.86M.
- USANA HEALTH SCIENCES, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2015 was $12.51M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 3 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 6 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 9 month | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2021-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $0.00 10-K · filed 2021-03-02 | ||
| 2020-09-26 | $0.00 10-Q · filed 2020-11-03 | |||
| 2019-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.00M derived: sum of 2 quarters · filed 2022-03-01 | $26.85M derived: sum of 3 quarters · filed 2022-03-01 | $63.54M 10-K · filed 2022-03-01 |
| 2019-09-28 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $26.85M derived: sum of 2 quarters · filed 2020-11-03 | $63.54M 10-Q · filed 2020-11-03 | |
| 2019-06-29 | $23.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $60.54M 10-Q · filed 2020-08-04 | ||
| 2019-03-30 | $36.69M 10-Q · filed 2020-05-05 | |||
| 2018-12-29 | $22.86M 10-K · filed 2021-03-02 | |||
| 2015-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.37M derived: sum of 2 quarters · filed 2017-03-01 | $6.81M derived: sum of 3 quarters · filed 2017-03-01 | $12.51M 10-K · filed 2017-03-01 |
| 2014-09-27 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $6.81M derived: sum of 2 quarters · filed 2015-11-12 | $12.51M 10-Q · filed 2015-11-12 | |
| 2014-06-28 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $9.14M 10-Q · filed 2015-08-12 | ||
| 2014-03-29 | $5.70M 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |